Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients

IntroductionCurrently there are no biomarkers that are predictive of when patients with type-2 diabetes (T2D) will progress to more serious kidney disease i.e., diabetic nephropathy (DN). Biomarkers that could identify patients at risk of progression would allow earlier, more aggressive treatment in...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Carla Harkin, Diego Cobice, Simon Brockbank, Stephanie Bolton, Frances Johnston, Anna Strzelecka, Joanne Watt, Mary Jo Kurth, John V. Lamont, Peter Fitzgerald, Tara Moore, Mark W. Ruddock
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2022-06-01
Ráidu:	Frontiers in Endocrinology
Fáttát:	diabetic nephropathy midkine sTNFR1 sTNFR2 L-FABP H-FABP
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fendo.2022.887237/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!